The aim of this study was to evaluate the performance of a commercially available multiplex real-time PCR assay and a PCR-reverse blot hybridization assay (PCR-REBA) for the rapid detection of bacteria and identification of antibiotic resistance genes directly from blood culture bottles and to compare the results of these molecular assays with conventional culture methods. The molecular diagnostic methods were used to evaluate 593 blood culture bottles from patients with bloodstream infections. The detection positivity of multiplex real-time PCR assay for Gram-positive bacteria, Gram-negative bacteria and Candida spp. was equivalent to PCR-REBA as 99.6 %, 99.1 % and 100 %, respectively. Using conventional bacterial cultures as the gold standard, the sensitivity, specificity, positive predictive value and negative predictive value of these two molecular methods were 99.5 % [95 % confidence interval (CI), 0.980-1.000; P<0.001), 100 % (95 % CI, 0.983-1.000; P<0.001), 100 % and 99 %, respectively. However, positivity of the Real-methicillin-resistant Staphylococcus aureus multiplex real-time PCR assay targeting the mecA gene to detect methicillin resistance was lower than that of the PCR-REBA method, detecting an overall positivity of 98.4 % (n=182; 95 % CI, 0.964-1.000; P<0.009) and 99.5 % (n=184; 95 % CI, 0.985-1.000; P<0.0001), respectively. The entire two methods take about 3 h, while results from culture can take up to 48-72 h. Therefore, the use of these two molecular methods was rapid and reliable for the characterization of causative pathogens in bloodstream infections.
INTRODUCTION
Bloodstream infections (BSIs) are associated with high rates of morbidity and mortality, with a mortality rate ranging from 20 % to 70 % (Melamed & Sorvillo, 2009) . The most prevalent causes of bacterial BSIs are the Gram-positive bacteria (GPB; 30-50 % of all cases), followed by Gram-negative bacteria (GNB) in 25-30 % of sepsis cases and fungal infections in 1-3 % of all sepsis cases (Grozdanovski et al., 2012) . Especially, the staphylococci are the most common GPB in blood cultures. Differentiating Staphylococcus aureus from coagulasenegative staphylococci (CoNS) is important because sepsis with Staphylococcus aureusis common and virulent, with mortality rates in the range of 20-30 % (Saginur & Suh, 2008) . Every hour of delay in the initiation of appropriate antimicrobial therapy increases mortality by 7.6 % in patients with septic shock (Kumar et al., 2009) . Therefore, the rapid and accurate identification of bacterial pathogens grown in blood cultures of patients with sepsis, including characterization of the pathogen to the species level and determination of its antibiotic susceptibility pattern, is crucial for the prompt initiation of appropriate and effective therapy to decrease related morbidity and mortality.
Laboratory diagnosis for the detection of bloodstream microbial pathogens usually requires incubation of the patients' blood specimens and can range from manual to semiautomated or fully automated systems. Increasingly, the trend is toward using fully automated, continuous-monitoring blood culture systems (CMBCS) . Although use of CMBCS allows for microbes to be identified and their susceptibility profiles to be tested, it presents several limitations in that the detection of bacterial growth requires approximately 48-72 h or more in the case of slow-growing pathogens or fungal infection. In addition, further antimicrobial susceptibility testing is necessary (Hassan et al., 2014) . In order to reduce the turnaround time for blood culture, molecular diagnostic methods have been applied to more rapidly identify pathogens and to simultaneously determine antimicrobial susceptibility profiles. Several PCR-based commercial assays, including fluorescencebased hybridization assays with peptide nucleic acid probes (PNA-FISH; AdvanDx) (Hensley et al., 2009) , multiplex PCR-ELISA (Hyplex Blood Screen; BAG) (Wellinghausen et al., 2004) , microarray assay (Prove-it Sepsis; Mobidiag) (Aittakorpi et al., 2012) , reverse line blot hybridization assay (Genotype BC test; Hain Lifescience) (Gülhan et al., 2011) , matrix-assisted laser desorption ionization-time-of-flight MS (MALDI-TOF MS; Sepsityper, Bruker Daltonics) (Idelevich et al., 2014; Angeletti et al., 2015) and multiplex real-time PCR assay (SeptiFast; Roche Diagnostics) (Fern andez-Cruz et al., 2013; Mongelli et al., 2015) . Among these, PCR-based analyses have become the most reliable method for the identification of pathogenic fungi from clinical specimens (Procop, 2007) . A diagnostic assay based on multiplex real-time PCR (Real Sepsis-ID; Optipharm) was developed for the rapid and accurate detection and identification of GPB, GNB and Candida spp. and the discrimination of methicillin-resistant Staphylococcus aureus (MRSA) from methicillin-susceptible staphylococci. The PCR-based reverse blot hybridization assay (PCR-REBA; REBA Sepsis-ID,Optipharm) was designed to distinguish GPB, GNB, Candida spp. and antibiotic resistance genes [i.e. mecA gene of methicillin-resistant Staphylococcus spp. and vanA and vanB genes of vancomycin-resistant enterococci (VRE)]. Discrimination of the major GPB, GNB or Candida spp. aetiologic agents and the accurate identification of bacterial species are important to determine the appropriate and effective therapy related to each blood sample. Currently, the PCR-REBA kit is only available from the sole supplier Optipharm for research use only. In this study, we evaluated the clinical utility of the multiplex real-time PCR and PCR-REBA methods compared to conventional culturing methods for the rapid differentiation of GPB, GNB and Candida spp. and the determination of antimicrobial resistance genes directly from positive blood culture (PBC) and negative blood culture (NBC). Blood cultures were scored as follows: those flagging a signal on the CMBCS between 1 and 5 days postinoculation, together with confirmation by Gram stain, were scored as 'positive', and those showing the absence of such a signal up to 5 days post-inoculation were scored as 'negative'.
METHODS
Study design and samples. To evaluate the diagnostic performance of the multiplex real-time PCR and PCR-REBA methods, blood culture samples from 593 patients who matched the criteria of systemic inflammatory response syndrome (SIRS) with suspected bacterial or fungal infection at the time of admission to the emergency room were collected at the Wonju Severance Christian Hospital from October 2013 to June 2015. SIRS was diagnosed when two or more of the following criteria were present (Bone et al., 2009) : fever (>38 C), heart rate (>90 beats min
À1
), respiratory rate (>20 breaths min
), white blood cell count (>12 000 or <4000 cells µl
). For accurate diagnosis of patients with suspected sepsis, we additionally determined delta neutrophil index (>2.7 %), which is the immature granulocyte fraction provided by a blood cell analyser (Seok et al., 2012) . To determine the specificity of multiplex real-time PCR and PCR-REBA, two infectious disease physicians interpreted the blood culture results based on clinical, laboratory and microbiological findings (Wang et al., 2015) . This study was approved by the Institutional Ethics Committee at Yonsei University Wonju College of Medicine (approval no. CR312055-002).
Blood culture and the collection of blood culture bottle samples. Three hundred and ninety-three PBC and 200 NBC samples from patients with a delta neutrophil index greater than 2.7 % (Seok et al., 2012) were collected consecutively. To avoid the redundancy of enrolled samples, only one blood culture sample per patient was allowed. The enrolled blood culture samples were simultaneously tested with the multiplex real-time PCR, PCR-REBA and conventional microbiological tests. The PBC samples were eligible for enrolment if they flagged with a positive signal between 1 and 5 days after inoculation with blood drawn from the patient, with the BACTEC FX (Becton Dickinson) blood culture systems or BacT/ALERT 3D (bioM erieux) with a positive Gram stain. Those blood culture systems use fluorescent technology to detect increases in CO 2 produced by microbial growth. When bacterial growth was noted by a positive signal in blood culture systems, the PBC bottles were removed, and a 1 ml aliquot of the culture-broth mixture was aseptically collected using a syringe and needle. This 1 ml aliquot was divided into two: 500 µl was used to perform a Gram stain and subcultured on sheep blood agar and MacConkey agar (BD Diagnostic Systems), incubated overnight at 37 C in a 5 % CO 2 incubator, and the remaining 500 µl was used to perform subsequent DNA extraction if the blood cultures were flagged positive. NBC samples were used if culture results were negative after 5 days of incubation in the blood culture system. After the blood culture bottles were removed from the blood culture system, 500 µl of blood suspension was collected and kept at À20˚C for subsequent DNA extraction. All the NBC bottles were incubated at 35 C until PCR results were obtained. MicroScan ® (Siemens Healthcare Diagnostics) overnight Pos BP Combo 28, MICro-STREP Plus, overnight Neg Combo 53 and Neg Combo 54 panels were used for the identification of GPB, streptococci and GNB. For the identification of Candida spp., VITEK 2 (bioM erieux) YST ID CARD assays were used. Antimicrobial susceptibility tests were performed by disk diffusion and broth microdilution methods. Interpretation was made in accordance with the Clinical Laboratory Standards Institute documents (M02-A12 and M100-S26).
DNA preparation. To determine the detection limit of the multiplex real-time PCR and PCR-REBA methods, one colony of each three reference strains (Staphylococcus aureus ATCC 29213, Escherichia coli ATCC 25922 and Candida albicans ATCC 36802) was suspended in 100 µl of DNA extraction solution (5 % Chelex-100; Bio-Rad Laboratories). The suspended bacterial solution was boiled for 10 min followed by centrifugation at 13 000 g for 10 min with the supernatant used as the DNA template.
The preparation of DNA template from PBC samples was conducted as follows. A 0.5 ml aliquot of blood suspension was taken directly from the blood culture samples and suspended in 1 ml of PBS (pH 8.0) followed by centrifugation at 13 000 g for 1 min. The supernatant was removed, and the pellet was resuspended in 1 ml erythrocyte lysis buffer (Sigma) with proteinase K or RNase A and centrifuged at 13 000 g for 1 min. This washing step was repeated twice, and the pellet was resuspended in DNA extraction solution as described above for the blood culture samples. The contents and purity of the extracted DNA were assayed by measuring absorbance at 260 and 280 nm using an Infinite 200 NanoQuant (Tecan) spectrophotometer.
Multiplex real-time PCR assay. Micro-organisms detected using the multiplex real-time PCR assays are shown in Table 1 . The multiplex real-time PCR assay was carried out using Real-GP (Gram-positive), Real-GN (Gram-negative) and Real-CAN (Candida), and the Real-MRSA test for Staphylococcus spp.-specific (Staphyl-P probe), Staphylococcus aureus-specific (Sau-P probe) and mecA-specific (mec-P probe) strains was simultaneously detected using the CFX-96 real-time PCR system (Bio-Rad), which was used for thermocycling and fluorescence detection. The real-time PCR amplification was performed in a total volume of 20 µl that contained 10 µl 2Â Thunderbird probe qPCR mix (Toyobo), 5 µl primer and TaqMan probe mixture, 5 µl template DNA and the three target-specific TaqMan probes that were labelled with different fluorophores (FAM, HEX and Cy5, respectively) . Each real-time PCR kit contains internal control (IC) DNA, which is used to indicate successful nucleic acid extraction and the quality of the sample and to check for the presence of PCR inhibitors in the reaction. The IC DNA is designed to have minimal sequence similarity to the target gene and serves to detect false negatives. Therefore, it does not directly compete with the amplification of the species-specific target in multiplex real-time PCR. When no target is detected, positive detection of IC DNA indicates the absence of PCR inhibition and indicates that the concentration of target in the sample is below the detection limit. If the extraction is successful, the sample quality is satisfactory and no inhibition is detected and the IC signal will show a constant value. Positive (Staphylococcus aureus, Escherichia coli and Candida albicans) and negative controls were included throughout the procedure. No template controls with molecular grade (DNAse/RNAse-free) water (Ultra pure water; WELGENE) instead of template DNA were incorporated in each assay under the following conditions: 95 C for 3 min followed by 40 cycles of 95 C for 20 s and 60 C for 40 s. Each sample was tested in duplicate, and all PCR runs were performed twice. The bacterial load was quantified by determining the cycle threshold (C T ), the number of PCR cycles required for the fluorescence to exceed a value significantly higher than the background fluorescence. A positive result was indicated when the C T value was less than 35 after observing signal formation of wavelength from each channel.
PCR-REBA. The pathogens and resistance genes targeted by REBA Sepsis-ID assay are shown in Table 1 . PCR was performed using a 20 µl reaction mixture (GeNet Bio) containing 2Â master mix (10 µl), 2 µl primer mixture, 5 µl sample DNA and 3 µl Ultra pure water (WELGENE), which were added to the final volume. The first 10 PCR cycles were composed of a denaturation at 95 C for 30 s, followed by annealing and extension at 60 C for 30 s. These 10 cycles were followed by 40 cycles of denaturation at 95 C for 30 s followed by annealing and extension at 54 C for 30 s. After the final cycle, samples were maintained at 72 C for 10 min to complete the synthesis of all strands. The amplified target was visualized as a single band corresponding to a length of 230 bp using the ChemiDoc system (Vilber Lourmat).
For REBA Sepsis-ID, the hybridization and washing processes were performed as follows: each sample was tested in duplicate, and all PCR-REBA runs were performed twice. In brief, biotinylated PCR products were denatured at 25 C for 5 min in denaturation solution, and then denatured single-stranded PCR products suspended in hybridization solution were incubated with REBA Sepsis-ID membrane strips at 55 C with shaking at 90 r.p.m. in the provided blotting tray for 30 min. The strips were then washed twice with gentle shaking in 1 ml washing solution for 10 min at 55 C, incubated at 25 C with 1 : 2000 diluted streptavidin-alkaline phosphatase conjugate (Roche Diagnostics) in conjugate diluent solution for 30 min and finally washed twice with 1 ml conjugate diluent solution at room temperature for 1 min. The colorimetric hybridization signals were visualized by the addition of a 1 : 50 dilution of the nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl alkaline-phosphatase-mediated staining solution (Roche Diagnostics) and then incubated until a colour change was detected. Finally, the band pattern was read and interpreted visually.
Sequence analysis. Samples with discrepant results between the molecular methods and the conventional identification methods were subjected to bacterial 16S rRNA gene and fungal internal transcribed spacer (ITS) DNA sequence analysis. The primer set used to amplify the target 16S rRNA gene was 5¢-CTACGGGAGGCAGCAGTRGGGAAT-3¢ (407F) and 5¢-TATTACCGCGGCTGCTGGCA-3¢ (608R), resulting in a 201 bp PCR product. The ITS region primer set included 5¢-CDY-ACSGCCCCATTCTTGTCTAC-3¢
(MF2) and 5¢-TGCGTTC-TTCATCGATGCCGGA-3¢ (CR2) resulting in a 230 bp PCR product. The amplified 16S rRNA gene and ITS region DNA were sequenced using an ABI 3730 automated DNA sequencer (Applied Biosystems) and the ABI Prism BigDye Terminator (Applied Biosystems) system. Obtained sequences were compared with sequences in the National Center for Biotechnology Information GenBank database for species assignment.
Statistical analysis. All statistical analyses were performed using Prism 5 software (GraphPad) and SPSS statistics software version 21.0 (IBM). The sensitivity, specificity and negative and positive predictive values of multiplex real-time PCR and PCR-REBA were analysed by kappa coefficient and its corresponding P value with a 95 % confidence interval (CI) of predictive ability.
RESULTS

Sample collection and bacterial identification
The most frequent suspected site of infection of 593 SIRS patients was pneumonia, acute gastroenteritis, urinary tract infection, abscess, cholangitis and cancer. Among them, 393 (66.3 %) PBCs and 200 (33.7 %) NBCs were identified. Overall, 62.1 % (n=244), 29.3 % (n=115) and 7.6 % (n=30) were found to contain GPB, GNB and Candida spp., respectively, based on primary Gram stains. Among the 393 PBCs, 99 % (n=389) were monomicrobial and 1 % (n=4) contained at least two bacterial species (Table 2) .
Analytical sensitivity of the multiplex real-time PCR and PCR-REBA methods Analytical sensitivity of the methods was determined through the use of a 10-fold dilution (10 ng, 1 ng, 100 pg, 10 pg, 1 pg, 100 fg and 10 fg) DNA standard curve extracted from Staphylococcus aureus, Escherichia coli and Candida albicans cultures. The multiplex real-time PCR assay detection limit for GPB, GNB and Candida was approximately 100 fg DNA per reaction. The C T values for GPB, GNB and Candida with each gDNA (genomic DNA) concentration ranged from 15.1 to 33.9, 15 to 33.1 and 15.7 to 34.1, respectively (Fig. 1a-c) . The Real-MRSA multiplex realtime PCR assay detection limit for Staphyl-P (Staphylococcus spp.-specific probe), Sau-P (Staphylococcus aureus-specific probe) and mec-P (mecA methicillin resistance) tests was 100 fg DNA per reaction. The C T values for Staphyl-P, Sau-P and mec-P with each gDNA concentrate ranged from 15.4 to 32.4, 15.5 to 31.9 and 15.1 to 34.1, respectively ( Fig. 1d-f) . Also, the PCR-REBA detection limit for Staphylococcus aureus, Escherichia coli and Candida albicans ranged from 100 fg to 10 fg DNA per reaction (Fig. 1g-i) .
Results of the multiplex real-time PCR and PCR-REBA methods with blood culture samples To evaluate the multiplex real-time PCR assay performance, a total of 593 blood culture samples were analysed. Among the 393 PBC samples, 243 (99.6 %) GPB, 114 (99.1 %) GNB and 30 (100 %) Candida spp. showed positive fluorescence signals for detection by the multiplex real-time PCR assay (Table 2) . Four multiple infections were detected among the positive samples with three in the GPB isolate group and one in the GNB isolate group. The concordant results between multiplex real-time PCR and culture methods were at 99.5 % (391/393). All blood culture samples had positive IC signals, and the C T values of 393 PBC and 200 NBC samples ranged from 23.39 to 33.66 (mean±SD, 27.70±1.60) and 22.47 to 33.40 (27.62±2.30), respectively (Table 3 ). The GPB, GNB and Candida spp. blood culture sample C T values ranged from 11.94 to 33.98 (SD, ±4.00), 12.33 to 31.66 (SD, ±4.30) and 21.20 to 30.73 (SD, ±2.40), respectively. Two bacterial species (GPB Peptostreptococcus magnus and GNB Sphingomonas paucimobilis) were not detected by either the multiplex real-time PCR or PCR-REBA methods.
To confirm multiplex real-time PCR assay results, REBA Sepsis-ID assay was performed with the same blood culture samples (Fig. 2) . The results between the conventional and PCR-REBA methods were all concordant except for two *Other bacteria that were identified by conventional method were 15 GPB (7 Micrococcus spp., 3 Corynebacterium spp., 2 Propionibacterium acnes, 1 Clostridium tertium, 1 Gram-positive rod and 1 Peptostreptococcus magnus) and 11 GNB (2 Aeromonas spp., 2 Providencia spp., 1 Moraxella catarrhalis, 1 Burkholderia cepacia, 1 Chryseobacterium indologenes, 1 Campylobacter sp., 1 Serratia marcescens, 1 Citrobacter freundii and 1 Sphingomonas paucimobilis), respectively. Two bacterial species (Peptostreptococcus magnus and Sphingomonas paucimobilis) were not detected by either the multiplex real-time PCR or PCR-REBA methods.
detected by culture were identified as Candida glabrata and Candida albicans by PCR-REBA and fungal ITS DNA sequence analysis, respectively. Among the four cases of polymicrobial bacteraemia, three were concordant between the standard identification method and PCR-REBA, but one case (Enterococcus avium, Staphylococcus epidermidis and Escherichia coli) showed positive results for only Enterococcus spp. and Staphylococcus spp. by the PCR-REBA (Table 4) . (Table 5) .
Results of the Real-MRSA multiplex real-time PCR assay with PBC samples
Comparison of results between conventional and molecular assays for methicillin susceptibility
In order to confirm results obtained with the multiplex real-time PCR assay, the PCR-REBA was performed with the same DNA samples, and both sets of results were compared to those obtained using conventional methods. All 185 staphylococcal positive samples from the Real-MRSA multiplex real-time PCR assays showed positive signals with GPB and Staphylococcus genus-specific probes in the REBA Sepsis-ID assays. Results from multiplex real-time PCR and PCR-REBA methods for detecting methicillin resistance were all concordant except for two cases ( Other GNB (11) 11 ( *One isolate identified as Corynebacterium jeikeium by culture was positive for the Staphylococcus spp.-specific probe and the mecA probe in the PCR-REBA confirmed as Staphylococcus hominis by 16S rRNA sequence analysis. †One Candida albicans and two Candida famata isolates detected by culture were identified as Candida glabrata and Candida albicans by PCR-REBA and fungal ITS sequence analysis, respectively.
method and PCR-REBA methods (positive for Staphylococcus spp. and the mecA gene); however, the multiplex realtime PCR assay results were discordant with the results of these two assays (negative with the mecA gene-specific probes). The other sample was identified as MRSA by the standard culture and PCR-REBA methods (positive for Staphylococcus spp., Staphylococcus aureus and the mecA gene), but the multiplex real-time PCR result was discordant with the results of these two assays (negative for Staphylococcus spp.-, Staphylococcus aureus-and the mecA gene-specific probes).
DISCUSSION
Several studies have shown that inadequate antimicrobial therapy is an independent risk factor for mortality and microbiological failure for severely ill patients with lifethreatening infections (Fraser et al., 2006; Sabatier et al., 2009) . The rapid and accurate identification of bacterial species and drug resistance genes such as MRSA and MRCoNS directly from PBCs is critical for the selection of appropriate antibiotics for the treatment of bacterial infections. Traditional phenotypic susceptibility results usually take an additional 1-2 days after a blood culture is reported to be positive. Some rapid susceptibility testing assays, such as shortened incubation of susceptibility tests via microfluidic systems, have been used to improve the speed of antimicrobial susceptibility testing results (Choi et al., 2013) . However, a growth-based method may in some instances not detect resistant pathogens, e.g. MRSA when using cefoxitin, due to the known heterogeneous expression of the mecA gene (He et al., 2013) . Therefore, diagnostic techniques that may be considered as complementary to traditional methods are increasingly required in the clinical microbiology laboratory. Recently, the MALDI-TOF MS has been described as a potentially useful tool for the detection of pathogens due to its advantages of speed (ca. 3 h on average), sensitivity, ease of use and cost-effectiveness (excluding the initially high expense of the equipment) (Angeletti et al., 2015) . Disadvantages include limited validated databases for all target organisms. The multiplex realtime PCR and PCR-REBA used in this study had similar characteristics; they were both rapid (turnaround time of 2-3 h), sensitive, specific, comparatively easy to perform and without the need for specialized laboratory equipment, except for a PCR machine and water bath.
The Real Sepsis-ID assays consist of Real-GP, Real-GN, Real-CAN and Real-MRSA for the detection of Staphylococcus spp., a Staphylococcus aureus-specific gene and the mecA gene. These multiplex real-time PCR assays are only able to determine GPB, GNB or Candida spp. for rapid screening of BSI, and they do not allow species or genus identification. Multiplex real-time PCR is a recognized technique offering a faster and effective technology for the rapid detection of bacterial infection relative to conventional PCR and other detection methods. The combination of excellent sensitivity and specificity and ease of performance enables the simultaneous detection of multiple species and minimizes the possibility of contamination as it eliminates the need for additional post-PCR processing of the samples, and speed has made real-time PCR technology appealing to the clinical microbiology laboratory (Espy et al., 2006) .
In this study, the concordance rate of the blood culture and the Real-GP, Real-GN and Real-CAN multiplex real-time PCR assays was 99.5 % (95 % CI, 0.979-1.000; P<0.001).
The sensitivity and specificity of these multiplex real-time PCR assays were 391/393 (99.5 %) and 200/200 (100 %), respectively. Also, using conventional microbial culture as the gold standard, the sensitivity, specificity and positive and negative predictive values of the PCR-REBA were 99.5 % (95 % CI, 0.980-1.000; P<0.001), 100 % (95 % CI, 0.983-1.000; P<0.001), 100 % and 99 %, respectively. PCR-REBA also showed good agreement with microbial culture results (k=0.992), which is similar to a previously reported sensitivity of 99 % and specificity of 100 % with the PNA-FISH assay (Hensley et al., 2009) , sensitivity of 96.6-100 % and specificity of 92.5-100 % with the Hyplex Blood Screen assay (Wellinghausen et al., 2004) or a sensitivity of 94 % and specificity of 96 % with the microarray-based Prove-it Sepsis assay (Aittakorpi et al., 2012) . In addition, sensitivity of the Real-MRSA multiplex real-time PCR and PCR-REBA was 98.4 % (n=182; 95 % CI, 0.964-1.000; P<0.009) and 99.5 % (n=184; 95 % CI, 0.985-1.000; P<0.0001), respectively. There was no significant difference between these molecular assays and the culture method (P=0.0001) and between the Real-MRSA multiplex real-time PCR and PCR-REBA methods (P=0.0001). This is higher than the previously reported sensitivities of 92 % with the Verigene Gram-positive blood culture nucleic acid test (Scott, 2013) , 97.5 % with the Microflex LT based on MALDI-TOF MS assay (Chan et al., 2015) and 97.1 % with the direct colorimetric PCR-gold nanoparticle assay (Chan et al., 2014) . The Real-MRSA multiplex RT-PCR assay results for detecting the three target genes were negative for all 208 nonstaphylococcal PBC samples. The overall sensitivities for detecting the three target genes of the Real-MRSA multiplex real-time PCR assay were 100 % (185/185 PBC samples) for Staphylococcus spp.-specific probe, 97.4 % (37/38 PBC samples) for Staphylococcus aureus-specific probe and 97.7 % (128/131 PBC samples) for mecA probe, respectively. In this study, we found that positivity of the multiplex real-time PCR assays for the detection of GPB, GNB or Candida spp. was the same as PCR-REBA positivity (99.5 %), but positivity of the multiplex real-time PCR assay for detection of the mecA gene was lower than PCR-REBA positivity, detecting an overall positivity of 98.4 % (vs 99.5 % with the PCR-REBA). PCR-REBA is a highly sensitive and specific probebased method where multiple oligonucleotide probes are immobilized on nitrocellulose strips, are hybridized with biotin-labelled PCR products and derived rapid results within 4 h (Ajbani et al., 2011) . Three samples were not detected by Real-MRSA multiplex real-time PCR, and two of these samples were positive for the mecA gene in the PCR-REBA and culture methods. The two samples were polymicrobial infection cases in which each patient was infected with either both Enterococcus avium and Staphylococcus epidermidis or Enterococcus faecalis and Staphylococcus aureus; however, the cases were negative for the Staphylococcus-specific probe, Staphylococcus aureus-specific probe and the mecA gene in the multiplex real-time PCR assays. One possible explanation for the negative results is that the sensitivity of the Real-MRSA real-time PCR for polymicrobial infection was lower than that of the PCR-REBA. One sample was resistant to oxacillin by culture methods, which the multiplex real-time PCR and PCR-REBA methods did not detect because the mecA gene was not amplified. Two isolates that were identified as Peptostreptococcus magnus and Sphingomonas paucimobilis by culture were not detected by the two molecular assays. It is likely that homology for the GPB-and GNB-specific probe sequences in the two assays are different in these two isolates. Four cases were not concordant with the results between conventional culture and PCR-REBA methods. One isolate identified as Corynebacterium jeikeium by culture was positive for the Staphylococcus spp.-specific probe and the mecA probe in the PCR-REBA and the Real-MRSA multiplex real-time PCR assay and was confirmed as Staphylococcus hominis by 16S rRNA gene sequence analysis.
Two other isolates identified as Candida famata and one identified as Candida albicans by culture methods were positive for Candida albicans and Candida glabrata probes in PCR-REBA, respectively, and were confirmed as Candida albicans and Candida glabrata by fungal ITS DNA sequencing. Candidiasis is a yeast infection caused by different Candida spp. and can cause opportunistic infections of the skin and mucosa as well as invasive infections. Invasive fungal infections are increasingly recognized as a primary cause of morbidity and mortality especially in immunocompromised patients. To reduce mortality in patients with invasive candidiasis, the early and accurate diagnosis and rapid initiation of antifungal therapy are very important for the survival of patients (Wellinghausen et al., 2009) . For Candida spp., the important causative organisms in BSI (Candida albicans, Candida glabrata, Candida parapsilosis and Candida tropicalis) were all correctly detected by the PCR-REBA.
Among the total 393 PBC samples, the most frequently identified pathogen infections were CoNS (n=147, 37.4 %), especially Staphylococcus epidermidis, which accounted for 47.6 % (n=70) of the CoNS isolates, followed by Escherichia coli (n=57, 14.5 %), Staphylococcus aureus (n=38, 9.7 %), Klebsiella spp. (n=23, 5.9 %) and Streptococcus spp. (n=23, 5.9 %). These results were similar to previous studies where the major causative micro-organisms identified included CoNS, Klebsiella spp., Acinetobacter spp. and Candida spp. (Morkel et al., 2014) ; CoNS, Staphylococcus aureus, Escherichia coli and Klebsiella spp. (Hansen et al., 2010) ; CoNS, Staphylococcus aureus, Pseudonomas spp. and Klebsiella spp. (Lucignano et al., 2011) ; CoNS, Staphylococcus aureus, Klebsiella spp. and Pseudonomas spp. (Ho et al., 2010) . Additionally, we tested the PCR-REBA with blood culture samples within 24 h incubation to minimize time for a more rapid detection; these results also showed 95.3 % sensitivity (95 % CI, 0.922-0.972; P<0.001) and good agreement with bacterial culture methods (k=0.971) (data not shown).
Results of the present study show that the multiplex realtime PCR assay is a rapid method with a turnaround time that usually takes 2 h, which included 30 min for DNA preparation and 1.5 h for target DNA amplification. It allowed for the rapid identification of GPB, GNB or Candida spp. and the mecA gene without a post-PCR process. The PCR-REBA molecular diagnostic assay not only identifies at the genus/species level in GPB, GNB or Candida spp. but also detects drug resistance directly from PBC samples within 3 h. However, PCR-REBA needs three additional steps that include hybridization (30 min), washing (20 min) and chromogenic and data interpretation (10 min). Therefore, it requires a fully automated system for the convenience of users.
There are potential limitations in this study. First, there were a limited number of MRSA (n=24) or VRE (n=2) samples compared to other studies because our participants were all selected from a single clinic site. Therefore, it will be necessary to conduct more tests with a larger number of drug-resistant confirmed samples. Second, two molecular assays were used in this study that only detect drug resistance genes in GPB (e.g. mecA and vanA or vanB); therefore, it will be necessary to add specific probes for extended-spectrum b-lactamases and carbapenemases for the detection of antibiotic-resistant GNB.
Use of the two molecular assays was rapid and reliable for identifying GPB, GNB or Candida spp. and the mecA gene to detect methicillin resistance directly from PBC samples and may therefore provide essential information to accelerate therapeutic decisions for earlier and adequate antibiotic treatment in the acute phase of pathogen infections.
